Free Trial
→ A grave, grave error. (From Porter & Company) (Ad)
OTCMKTS:DGNOF

DIAGNOS 5/28/2025 Earnings Report

DIAGNOS logo
$0.14 0.00 (-1.06%)
As of 06/26/2025 03:21 PM Eastern
ProfileEarnings History

DIAGNOS EPS Results

Actual EPS
-$0.01
Consensus EPS
-$0.01
Beat/Miss
Missed by -$0.00
One Year Ago EPS
N/A

DIAGNOS Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
$0.09 million
Beat/Miss
Missed by -$78.00 thousand
YoY Revenue Growth
N/A

DIAGNOS Announcement Details

Quarter
Date
5/28/2025
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

DIAGNOS' next earnings date is estimated for Wednesday, July 16, 2025, based on past reporting schedules.

Conference Call Resources

DIAGNOS Earnings Headlines

DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States
June 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/10/3096992/0/en/diagnos-welcomes-founder-of-national-vision-associates-ed-weiner-to-its-advisory-board-for-the-united-states.html
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
June 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/04/3093391/0/en/diagnos-welcomes-former-white-house-economic-adviser-dr-tomas-j-philipson-to-its-advisory-board-for-the-us-market.html
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
June 27 at 2:00 AM  |  Porter & Company (Ad)
DIAGNOS Engages Allele Capital for Strategic Advisory
May 23, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diagnos-engages-allele-capital-for-strategic-advisory?utm_source=marketbeat.com&utm_medium=referral
DIAGNOS Announces the Engagement of Allele Capital Partners
May 23, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/23/3087631/0/en/diagnos-announces-the-engagement-of-allele-capital-partners.html
DIAGNOS Announces Amendment to Convertible Debentures
May 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/20/3085241/0/en/diagnos-announces-amendment-to-convertible-debentures.html
See More DIAGNOS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email.

About DIAGNOS

DIAGNOS (OTCMKTS:DGNOF) provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

View DIAGNOS Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles